African Union and the Africa Centers for Disease Control and Prevention’s Africa Regulatory Taskforce has endorsed the Emergency Used Authorization for Janssen COVID-19 Vaccine
10 March 2021
If you have the choice of more than one vaccine and are wondering which one to take and how to assess the risk of side effects, this episode of Science in 5 with WHO’s Dr Katherine O’Brien is for you.
This guidance document provides basic principles for a spokesperson of any health authority on how to respond to vocal vaccine deniers. The suggestions are based on psychological research on persuasion, on research in public health, communication st...udies and on WHO risk communication guidelines.
more
The CVIC tool is the WHO-UNICEF tool designed to assist countries in the process of planning and costing COVID-19 vaccination. The aim of this course is to demonstrate the use of the CVIC tool. The course is targeting national programme managers and... personnel who have been involved in the costing, budgeting or financing processes of COVID-19 vaccine delivery in a country.
more
orientations provisoires, première publication: 10 février 2021, mise à jour : 21 avril 2021, dernière mise à jour : 30 juillet 2021
updated version: 04/10/2021
Information about vaccine administration
Learn about the first Malaria vaccine. Who should receive this vaccine? What are the challenges of rolling out a Malaria vaccine in the midst of a ...pandemic? Dr Pedro Alonso explains in Science in 5 this week.
more
Overview
16 Dec 2021. This interim guidance pertains to heterologous primary and heterologous boosting schedules of Covid-19 vaccines. It focuses on heterologous schedules combining multiple vaccine...> platforms (e.g. a vectored vaccine followed by an mRNA vaccine).
more
17 Febr. 2022. As part of the “Strategy to Achieve Global COVID-19 Vaccination by mid-2022”, global targets of 40% population coverage by end of 2021 and 70% coverage by June 2022 have been set by the World Health Organization (WHO), to successf...ully prevent severe illness and deaths, minimize social disruption and economic consequences of COVID-19, curtail the emergence of new SARS-CoV-2 variants of concern (VOCs) and ultimately control the pandemic.
more
News Release 11 april 2022
This policy brief draws from the latest evidence on the impact of vaccination program start date and vaccine rollout rates on health benefits. The objective is to support policymakers on decisions t...o procure COVID-19 vaccines and roll out vaccination programmes in countries, especially those
where large proportions of the population remain unvaccinated.
more
Mass vaccination campaigns to prevent coronavirus disease 2019 (Covid-19) are occurring in many countries; estimates of vaccine effectiveness are urgently needed
to support decision making. A coun...trywide mass vaccination campaign with the
use of an inactivated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
vaccine (CoronaVac) was conducted in Chile starting on February 2, 2021.
more